Medline Inc.
MDLN
$38.55
-$0.70-1.78%
NASDAQ
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Revenue | 29.14B | 28.43B | 27.43B | 26.70B | 26.00B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.14B | 28.43B | 27.43B | 26.70B | 26.00B |
| Cost of Revenue | 21.61B | 20.91B | 19.97B | 19.37B | 18.91B |
| Gross Profit | 7.54B | 7.52B | 7.46B | 7.34B | 7.09B |
| SG&A Expenses | 4.72B | 4.56B | 4.46B | 4.33B | 4.22B |
| Depreciation & Amortization | 705.00M | 704.00M | 705.00M | 701.00M | 693.00M |
| Other Operating Expenses | 67.00M | 60.00M | 46.00M | 60.00M | 48.00M |
| Total Operating Expenses | 27.10B | 26.23B | 25.18B | 24.45B | 23.87B |
| Operating Income | 2.05B | 2.20B | 2.25B | 2.25B | 2.14B |
| Income Before Tax | 1.20B | 1.25B | 1.35B | 1.34B | 1.28B |
| Income Tax Expenses | 127.00M | 91.00M | 81.00M | 72.00M | 54.00M |
| Earnings from Continuing Operations | 1.07K | 1.16K | 1.27K | 1.27K | 1.23K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -108.00M | 2.00M | -- | -- | -- |
| Net Income | 966.00M | 1.16B | 1.27B | 1.27B | 1.23B |
| EBIT | 2.05B | 2.20B | 2.25B | 2.25B | 2.14B |
| EBITDA | 3.06B | 3.21B | 3.25B | 3.25B | 3.12B |
| EPS Basic | 0.42 | 0.28 | 0.07 | 0.05 | 0.03 |
| Normalized Basic EPS | 0.33 | 0.24 | 0.04 | 0.02 | 0.01 |
| EPS Diluted | 0.42 | 0.28 | 0.07 | 0.05 | 0.03 |
| Normalized Diluted EPS | 0.33 | 0.24 | 0.04 | 0.02 | 0.01 |
| Average Basic Shares Outstanding | 36.61B | 35.79B | 52.45B | 34.97B | 17.47B |
| Average Diluted Shares Outstanding | 36.62B | 53.26B | 69.92B | 52.44B | 34.93B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 22.26% | 18.55% | 116.75% | 110.49% | 118.95% |